Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·How a sleep-apnea study pairs breathing-muscle tests with whole-body function
Clinical TrialA registry study pairs pressure, peak-flow, spirometry, grip and walking tests to examine breathing-muscle weakness in sleep apnea; results are not posted.
-
Evidence date ·What a small ultrasound trial could reveal about tinnitus and sleep
Clinical TrialA 14-person active-versus-sham trial will track tinnitus, sleep, attention and word learning after low-intensity ultrasound. Results are not yet posted.
-
Evidence date ·Can earlier sleep-apnea treatment help thinking in older adults?
Clinical TrialA registered trial compares immediate and delayed sleep-apnea treatment, tracking cognitive tests and blood markers. The supplied record has no results.
-
Evidence date ·What would online meditation ask of people with mild cognitive impairment or mild dementia?
Clinical TrialA UK study plan describes weekly classes, daily practice and measures of participation, satisfaction, cognition, sleep and mood; the registry lists no posted results.
-
Evidence date ·How the brain’s wakefulness system connects disrupted sleep with Alzheimer’s disease
Review or Meta-AnalysisA 2025 review explores orexin’s role in sleep and Alzheimer’s. Findings in people conflict, and sleep benefits do not establish slower disease progression.
-
Evidence date ·What a Cortexium trial is testing about memory after menopause
Clinical TrialA placebo-controlled Cortexium trial measures cognition over six weeks in postmenopausal women; registry results have not been posted.
-
Evidence date ·An early Parkinson’s study follows movement, balance and thinking
Clinical TrialTracked over timeAn observational study compares proposed Parkinson’s patterns through walking tests, imaging and biomarkers, while individual prognosis remains untested.
-
Evidence date ·What do body-first and brain-first Parkinson’s labels reveal?
Peer-Reviewed PaperTracked over timeResearchers linked early sleep and autonomic symptoms to later Parkinson’s progression, while showing why group findings are not an individual prognosis.
-
Evidence date ·Why unexplained nerve damage is being studied for early Parkinson’s
Clinical TrialTracked over timeAn observational study compares heart-nerve scans and sleep in people with unexplained nerve damage, with five-year follow-up planned and no registry results posted.
-
Evidence date ·A temporary reset made a diverse library of tissue-supporting cell lines
Peer-Reviewed PaperTracked over timeHuman tissue-supporting cells divided for longer after a temporary reset, but their profiles shifted and therapeutic safety remains unproven.